Abemaciclib
Brand name: Verzenio
Rank #77 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$242.2M
Total Cost
16,125
Total Claims
$242.2M
Total Cost
787
Prescribers
$15K
Cost per Claim
37
Beneficiaries
16,177
30-Day Fills
$308K
Avg Cost/Provider
20
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$242.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $242.2M total
🔎 Data Overview
At $15,018 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $307,698 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $6,544,829 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Abemaciclib
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Tammy Young | Hematology-Oncology | Jackson, MS | 80 | $1.3M |
| 2 | Rupa Subramanian | Hematology-Oncology | Vista, CA | 87 | $1.3M |
| 3 | Vipin Ramprasad Lohiya | Hematology-Oncology | Fayetteville, GA | 78 | $1.2M |
| 4 | Wajeeha Razaq | Hematology-Oncology | Oklahoma City, OK | 78 | $1.2M |
| 5 | Kathy Sam | Hematology-Oncology | Houston, TX | 72 | $1.2M |
| 6 | Jamie Mckenzie | Medical Oncology | Tampa, FL | 77 | $1.1M |
| 7 | Luis Baez Vallecillo | Hematology-Oncology | San Juan, PR | 74 | $1.1M |
| 8 | Laura Kennedy | Hematology-Oncology | Nashville, TN | 86 | $1.1M |
| 9 | Ruemu Birhiray | Hematology-Oncology | Indianapolis, IN | 68 | $1.1M |
| 10 | Dawn Klemow | Hematology-Oncology | Dallas, TX | 69 | $1.0M |
| 11 | Sameer Gupta | Hematology-Oncology | Bryn Mawr, PA | 78 | $1.0M |
| 12 | Antoine Chahine | Medical Oncology | Canfield, OH | 63 | $988K |
| 13 | Phyu Phyu Soe | Nurse Practitioner | Mineola, NY | 64 | $966K |
| 14 | Johnny Chang | Hematology-Oncology | Encino, CA | 65 | $963K |
| 15 | Ying Chen | Nurse Practitioner | Flushing, NY | 55 | $872K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
| 75 | Metoprolol Succinate (Metoprolol Succinate) | $256.3M | 12,847,535 |
| 76 | Dolutegravir Sodium (Tivicay) | $251.7M | 102,995 |
| 77 | Abemaciclib (Verzenio) | $242.2M | 16,125 |
| 78 | Abacavir/Dolutegravir/Lamivudi (Triumeq) | $238.1M | 61,147 |
| 79 | Riociguat (Adempas) | $236.6M | 17,620 |
| 80 | Elviteg/Cob/Emtri/Tenof Alafen (Genvoya) | $236.5M | 56,626 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology